Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for pain relief after unilateral total knee arthroplasty
IRCT20230215057432N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postoperative pain and Chronic Pain after Total Knee Arthroplasty (CP-TKA), sponsored by Mashhad University of Medical Sciences. Started Mar 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative painChronic Pain after Total Knee Arthroplasty (CP-TKA)
Beyond the preview
Go deeper on IRCT20230215057432N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230215057432N1.